About JCR Pharmaceuticals
JCR Pharmaceuticals is a publicly listed company based in Japan founded in 1975. Biosimilars and cell therapies are manufactured and commercialized. The company has 987 employees. JCR Pharmaceuticals has completed 1 acquisition, including ArmaGen. Its website jcrpharm.co.jp draws about 12 thousand monthly visits. Its focus areas include Diversified Pharmaceuticals.
Company details
Founded in 1975 and based in Hyogo, Japan, JCR Pharmaceuticals operates in the biotechnology sector. Biosimilars and cell therapies are produced and marketed by the company, with three products available in the Japanese market: an allogeneic mesenchymal stem cell product known as Temcell, recombinant human growth hormone, and recombinant erythropoietin. Seven additional recombinant proteins are under clinical development.
- Headquarters Hyogo, Japan
- Employees 987
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website jcrpharm.co.jp/en/site/en/index.html
- Social LinkedIn
- Legal Name Jcr Pharmaceuticals Co., Ltd.
Funding Insights of JCR Pharmaceuticals
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of JCR Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2008 | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in JCR Pharmaceuticals
JCR Pharmaceuticals has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TPG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States |
Investor details for JCR Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of JCR Pharmaceuticals
JCR Pharmaceuticals is a publicly listed company on the TSE with ticker symbol 4552 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Mar 2011
- Listed onTSE: 4552
- Listed entityJCR Pharmaceuticals Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3701000006
- Share price523.00 JPY (-1.88% on the day) · 2026-10-14
- Market capitalisation65,959,156,647.00 JPY
- Price to earnings74.7
- EPS (diluted, trailing year)7.00 JPY
- Dividend yield3.75%
- Volume (last session)989,900
Financials of JCR Pharmaceuticals
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 40.32B JPY | 2.18B JPY | 2.99B JPY |
| 2024 | 33.07B JPY | -4.46B JPY | -3.04B JPY |
| 2023 | 42.87B JPY | 5.51B JPY | 10.73B JPY |
| 2022 | 34.34B JPY | 3.77B JPY | 6.97B JPY |
| 2021 | 51.08B JPY | 14.51B JPY | 21.88B JPY |
Detailed financial statements for JCR Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JCR Pharmaceuticals
JCR Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ArmaGen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapies for severe neurological disorders are developed via BBB-crossing technology. | armagen.com | United States | 2004 | Mar 2020 | •••• |
Complete acquisition details for JCR Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of JCR Pharmaceuticals
4 dated milestones of JCR Pharmaceuticals across 45 years, from founding to its latest funding, stage changes and deals.
- Founded JCR Pharmaceuticals is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ArmaGen.
Web traffic of JCR Pharmaceuticals
The website of JCR Pharmaceuticals (jcrpharm.co.jp) receives about 11.5K visits a month and ranks #1,466,176 among all websites worldwide, #1,915 in Biotechnology and Pharmaceuticals.
- Monthly visits11.5K
▼ 25.8% vs previous month
- Unique visitors6.5K
per month
- Global rank#1,466,176
among all websites
- Category rank#1,915
Health · Biotechnology and Pharmaceuticals
- Bounce rate53%
- Pages per visit2.4
- Average visit46 sec
- DevicesDesktop 42% · Mobile 58%
Websites whose visitors overlap most with JCR Pharmaceuticals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| torii.co.jp | 100% | 33.9K | #963,035 | View details | |
sandoz.jp | sandoz.jp | 97% | #1,721,119 | – | |
mylan.co.jp | mylan.co.jp | 97% | – | ||
fri.fujifilm.co.jp | fri.fujifilm.co.jp | 97% | – | ||
npi-inc.co.jp | npi-inc.co.jp | 97% | #3,189,092 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for JCR Pharmaceuticals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jcr Pharmaceuticals
Complete news archive for JCR Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JCR Pharmaceuticals
JCR Pharmaceuticals was founded in 1975 and raised its 1st funding round 33 years after it was founded.
JCR Pharmaceuticals is headquartered in Japan. It is registered at Hyogo, Japan.
JCR Pharmaceuticals has 987 employees.
Annual revenue of JCR Pharmaceuticals is $252.79M as on Mar 31, 2026.
Founded in 1975 and based in Hyogo, Japan, JCR Pharmaceuticals operates in the biotechnology sector. Biosimilars and cell therapies are produced and marketed by the company, with three products available in the Japanese market: an allogeneic mesenchymal stem cell product known as Temcell, recombinant human growth hormone, and recombinant erythropoietin. Seven additional recombinant proteins are under clinical development.
Yes, JCR Pharmaceuticals is publicly traded on TSE under the ticker symbol 4552.
JCR Pharmaceuticals has made 1 acquisition, including ArmaGen.
JCR Pharmaceuticals has 1 investor. Key investors include TPG.